Dr. Kudchadkar on the FDA Approval of Avelumab in Merkel Cell Carcinoma
0 Visningar
• 07/17/23
0
0
Bädda in
administrator
Prenumeranter
Ragini Kudchadkar, MD, assistant professor, Department of Hematology and Medical Oncology, associate director, Hematology and Medical Oncology Fellowship Program-Clinical/Service, Emory University School of Medicine, discusses the FDA approval of avelumab for the treatment of patients with Merkel cell carcinoma.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna